Patents by Inventor Guy Jean Marie Fernand Pierre Baudoux

Guy Jean Marie Fernand Pierre Baudoux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant RSV vaccines
    Patent number: 9492531
    Abstract: This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.
    Type: Grant
    Filed: June 24, 2010
    Date of Patent: November 15, 2016
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Guy Jean Marie Fernand Pierre Baudoux, Normand Blais, Sonya L. Cyr, Patrick Rheault, Jean-Louis Ruelle
  • RECOMBINANT RSV ANTIGENS
    Publication number: 20160122398
    Abstract: This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.
    Type: Application
    Filed: January 8, 2016
    Publication date: May 5, 2016
    Inventors: Guy Jean Marie Fernand Pierre Baudoux, Jean-Louis Ruelle, Normand Blais, Patrick Rheault
  • RECOMBINANT RSV ANTIGENS
    Publication number: 20150166610
    Abstract: This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.
    Type: Application
    Filed: October 14, 2013
    Publication date: June 18, 2015
    Inventors: Guy Jean Marie Fernand Pierre BAUDOUX, Jean-Louis Ruelle, Normand Blais, Patrick Rheault
  • Recombinant RSV antigens
    Patent number: 8563002
    Abstract: This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.
    Type: Grant
    Filed: December 23, 2008
    Date of Patent: October 22, 2013
    Assignee: GlaxoSmithKline Biologicals, S.A.
    Inventors: Guy Jean Marie Fernand Pierre Baudoux, Normand Blais, Patrick Rheault, Jean-Louis Ruelle
  • CYTOMEGALOVIRUS GB ANTIGEN
    Publication number: 20130216613
    Abstract: The invention relates to a cytomegalovirus (CMV) gB polypeptide comprising at least a portion of a gB protein extracellular domain comprising a fusion loop 1 (FL1) domain and a fusion loop 2 (FL2) domain, wherein at least one of the FL1 and FL2 domains comprises at least one amino acid deletion or substitution.
    Type: Application
    Filed: October 14, 2011
    Publication date: August 22, 2013
    Inventors: Guy Jean Marie Fernand Pierre Baudoux, Normand Blais, Martine Marchand
  • RECOMBINANT RSV VACCINES
    Publication number: 20120093847
    Abstract: This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.
    Type: Application
    Filed: June 24, 2010
    Publication date: April 19, 2012
    Inventors: Guy Jean Marie Fernand Pierre Baudoux, Normand Blais, Sonya L. Cyr, Patrick Rheault, Jean-Louis Ruelle
  • NOVEL COMPOSITIONS
    Publication number: 20120087937
    Abstract: This disclosure provides novel human papillomavirus (HPV) protein constructs and their use in the prevention of HPV disease. The constructs are chimeric proteins comprising L1 proteins with an HPV L2 peptide inserted in to the L1 protein. Such chimeric proteins may be formulated into immunogenic e.g., vaccine compositions, and optionally formulated with HPV L1 VLP based vaccines.
    Type: Application
    Filed: June 24, 2010
    Publication date: April 12, 2012
    Inventors: Brigitte Desiree Alberte Colau, Najoua Dendouga, Sandra Giannini, Nicolas Pierri Fernand Lecrenier, Guy Jean Marie Fernand Pierre Baudoux
  • RECOMBINANT RSV ANTIGENS
    Publication number: 20100291147
    Abstract: This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.
    Type: Application
    Filed: December 23, 2008
    Publication date: November 18, 2010
    Inventors: Guy Jean Marie Fernand Pierre Baudoux, Normand Blais, Patrick Rheault, Jean-Louis Ruelle